Skip to main content
Clinical Trials/NCT05578807
NCT05578807
Recruiting
Not Applicable

A Comparative Study of Retrograde Ureteral Catheter Insertion or Not in Total Tubeless Percutaneous Nephrolithotomy

The First Affiliated Hospital of University of South China1 site in 1 country100 target enrollmentSeptember 28, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Nephrolithotomy, Percutaneous
Sponsor
The First Affiliated Hospital of University of South China
Enrollment
100
Locations
1
Primary Endpoint
visual analog scale (VAS)pain score
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

Total tubeless Percutaneous nephrolithotomy (PCNL) is a modified surgical method of PCNL surgery, that is, there is no indwelling nephrostomy tube and double-J tube during PCNL surgery. Compared with traditional PCNL surgery, it has the advantages of reducing pain, shortening operation time and reducing operation cost. Since this procedure was first performed in 2004, several randomized clinical studies have verified the safety and efficacy of total tubeless PCNL. Conventional total tubeless PCNL surgery requires the patient to first undergo retrograde transurethral ureteroscopic insertion of the ureteral catheter in the lithotomy position, and then change the patient to the prone position. However, a large number of literature reports and the surgical experience of PCNL in the past 20 years tell the investigators that the reverse insertion of ureteral catheter can cause many recent surgical complications.The study planned to perform the operation in the prone position without reverse insertion of a ureteral catheter in the total tubular PCNL surgery.

Detailed Description

The purpose of this single-center, single-blind, randomized trial was to investigate whether without retrograde insertion of a ureteral catheter is appropriate for total tubeless percutaneous nephrolithotomy. It is planned to start in October 2022 and is expected to end in October 2024. Based on inclusion and exclusion criteria, 100 subjects were expected to be recruited. In a parallel group design, subjects were randomly assigned to two groups: the experimental group received total tubeless PCNL without reverse insertion of a ureteral catheter , and the control group received conventional total tubeless PCNL. The primary end point of the study was the incidence of postoperative complications according to the modified Clavien-Dindo complication grading system. Secondary end points included Stone-free rate, operation time, length of hospital stay, and medical costs. Measurement data were expressed as mean ± standard deviation (X ± S), and Student's t-test was used for intergroup comparisons. The counting data were expressed as frequency and percentage, and the chi-squared or Fisher's exact probability test were used for intergroup comparisons. The rank-sum test was used for grade data. P\<0.05 was considered statistically significant.

Registry
clinicaltrials.gov
Start Date
September 28, 2022
End Date
January 10, 2025
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
The First Affiliated Hospital of University of South China
Responsible Party
Principal Investigator
Principal Investigator

Li Mingyong, MD

Associate professor

The First Affiliated Hospital of University of South China

Eligibility Criteria

Inclusion Criteria

  • patients with kidney stones who met the indications for PCNL surgery.
  • the maximum diameter of calculi was less than 35 mm.
  • the width of hydronephrosis effusion was less than 25mm.

Exclusion Criteria

  • patients with infectious calculi confirmed by preoperative CT examination and blood biochemical indexes.
  • Patients with severe cardiac and pulmonary insufficiency, coagulation dysfunction and other obvious surgical contraindications.
  • Patients with previous history of PCNL surgery on the affected side or nephrotomy.
  • Patients with indwelling double J tube or nephrostomy tube before operation.
  • Patients with renal trauma or congenital anomalies of urinary system.

Outcomes

Primary Outcomes

visual analog scale (VAS)pain score

Time Frame: Hour 2 after the surgery

0: no pain; Less than 3 points: mild pain, tolerable; 4 points to 6 points: the patient's pain and affect sleep, still tolerable; 7-10: Patients have increasing pain, pain is unbearable, affect appetite, affect sleep.

Rate of hydrothorax

Time Frame: Day 2 after the surgery

Hydrothorax appeared on the surgical side.

White blood cell count change value

Time Frame: Day 2 before surgery、hour 3 after the surgery

The change value of White blood cell count between preoperative and

Hemoglobin change value

Time Frame: Day 2 before surgery、hour 3 after the surgery

The change value of Hemoglobin between preoperative and postoperative

Serum creatinine change value

Time Frame: Day 2 before surgery、Hour 3 after the surgery

The change value of Serum creatinine between preoperative and postoperative

Neutrophils granulocyte change value

Time Frame: Day 2 before surgery、hour 3 after the surgery

The change value of Neutrophils granulocyte between preoperative and postoperative

Hematocrit change value

Time Frame: Day 2 before surgery、hour 3 after the surgery

The change value of Hematocrit between preoperative and postoperative

Rate of fever

Time Frame: From the day of surgery to the day of discharge, up to 2 weeks.

Fever was defined as axillary temperature greater than 38.5 ° C.

Rate of renal subcapsular hematoma

Time Frame: Day 2 after the surgery

The proportion of postoperative renal subcapsular hematoma in all patients

Secondary Outcomes

  • Operation time(During the procedure)
  • Stone free rate(Day 2 after the surgery)
  • Medical costs(2 weeks after surgery)
  • length of hospital stay(2 weeks after surgery)

Study Sites (1)

Loading locations...

Similar Trials